In a post-hoc analysis from the Phase III ARANOTE trial, new results show metastatic castration-sensitive prostate cancer ...

A Fox News panelist broke down while opening up about her stage 3 cancer diagnosis while discussing Joe Biden's own battle ...

A new treatment approach is giving men with advanced prostate cancer more years to live.

Former President Joe Biden recently made his first public appearances after announcing his cancer diagnosis to celebrate his ...

The diagnosis came after he experienced urinary symptoms and underwent medical evaluation. His Gleason score of 9 indicates a high-grade cancer, but doctors say it is hormone-sensitive and potentially ...

Despite these clinical milestones and ongoing innovation, including first-in-human studies of new oncology drugs, Pfizer Inc.

Manhattan internist Dr Stuart Fischer recently weighed in on Joe Biden's Gleason score 9 prostate cancer diagnosis ...

Astellas & Pfizer’s Xtandi shows long-term overall survival in metastatic hormone-sensitive prostate cancer: Tokyo Saturday, May 24, 2025, 13:00 Hrs [IST] Astellas Pharma Inc. a ...

Astellas Pharma (ALPMY) and Pfizer (PFE) announced longer-term follow-up results from an open-label extension of the Phase 3 ...

Here’s what you should know about PSA screening, why medical guidelines vary and why individualized approaches are essential ...

Doctors examine a tumor in several different ways to determine whether a cancer is aggressive – and what kinds of treatments, if any, might work best.

Five- and eight-year trial data to be presented at ASCO demonstrate durable survival outcomes with Xtandi (enzalutamide) plus ...